利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

2093 条记录 (耗时 0.029 秒)

    Tamper evident container closure
    85.
    发明公开
    Tamper evident container closure 失效
    OriginalitätsverschlussfürBehälter。

    公开(公告)号：EP0548838A2

    公开(公告)日：1993-06-30

    申请号：EP92121583.6

    申请日：1992-12-18

    申请人： CPC INTERNATIONAL INC.

    发明人： Keller, Robert G.

    IPC分类号： B65D79/00

    CPC分类号： B65D79/005

    摘要： A tamper evident closure for a container has a seal member (14) which is in a concave or convex condition to show closure integrity. The seal (14) is visible through an opening (13) in the cover (10) of the container. Filling the container under pressure which is higher or lower than atmospheric produces the distention or contraction of the seal member (14) that evidences that no tampering or leakage has occurred.

    摘要翻译： 用于容器的防拆封闭件具有密封构件，该密封构件处于凹或凸状态以显示封闭完整性。 通过容器盖中的开口可以看到密封。 在高于或低于大气压的压力下填充容器会产生密封件的膨胀或收缩，这表明没有发生篡改或泄漏。

    Pharmaceutical compositions with angiotensin-II-antagonistic activity
    87.
    发明公开
    Pharmaceutical compositions with angiotensin-II-antagonistic activity 失效
    Arzneimittel mit血管紧张素II拮抗剂Wirkung。

    公开(公告)号：EP0546358A2

    公开(公告)日：1993-06-16

    申请号：EP92119705.9

    申请日：1992-11-19

    申请人： TAKEDA CHEMICAL INDUSTRIES, LTD.

    发明人： Makino, Tadashi, ,  Mizukami, Yoshio ,  Kikuta, Jun-ichi

    IPC分类号： A61K31/415 ,  A61K31/41 ,  A61K31/435 ,  A61K31/495 ,  A61K31/53

    CPC分类号： A61K31/53 ,  A61K9/2013 ,  A61K9/2018 ,  A61K9/2031 ,  A61K9/2054 ,  A61K31/41 ,  A61K31/415 ,  A61K31/4184 ,  A61K31/435 ,  A61K31/495

    摘要： A pharmaceutical composition for oral use comprising an effective amount of a compound of the formula (I) having antagonistic action to angiotensin II

    (wherein the ring W is an optionally substituted N-containing heterocyclic residue; R 3 is a group capable of forming an anion or a group convertible thereinto; X is a direct bond or a spacer having an atomic length of two or less between the phenylene group and the phenyl group; and n is an integer of 1 or 2) and an oleaginous substance having a lower melting point, and a method for preparing a pharmaceutical composition for oral use comprising an effective amount of a compound of the formula (I) and an oily substance having a lower melting point, which comprises admixing the compound of the formula (I) with an oily substance having a lower melting point and then subjecting the mixture to molding.

    摘要翻译： 一种用于口服的药物组合物，其包含有效量的对血管紧张素II 具有拮抗作用的式（I）化合物（其中环W为任选取代的含N杂环残基; R 3为基团 能够形成阴离子或可转换的基团; X是亚苯基和苯基之间的原子长度为2以下的直接键合或间隔基，n为1或2的整数）和含油物质 具有较低熔点的方法和用于制备口服药物组合物的方法，其包含有效量的式（I）化合物和具有较低熔点的油状物质，其包括将式（I ）与具有较低熔点的油状物质混合，然后使混合物成型。

    Increasing adhesion of dry-film photopolymerizable compositions to carriers
    89.
    发明公开
    Increasing adhesion of dry-film photopolymerizable compositions to carriers 失效
    增加可光聚合干膜的组合物在载体上的粘附性。

    公开(公告)号：EP0540050A1

    公开(公告)日：1993-05-05

    申请号：EP92118702.7

    申请日：1992-11-01

    申请人： HERCULES INCORPORATED

    发明人： Mayes, Richard Thomas

    IPC分类号： G03F7/033

    CPC分类号： G03F7/033 ,  Y10S430/11

    摘要： An aqueous-developable dry-film photopolymerizable composition is disclosed wherein the photopolymerizable composition contains a hydroxyl-modified vinyl chloride/vinyl acetate polymer.

    摘要翻译： 在wässrige显影的干膜可光聚合的组合物是游离缺失盘worin光聚合性组合物中含有的羟基改性氯乙烯/乙酸乙烯酯聚合物。